http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0474517-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 |
filingDate | 1991-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1998-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dc5132b601c6c0278b0c7c1398510a3 |
publicationDate | 1998-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0474517-B1 |
titleOfInvention | Novel use of 1alpha-hydroxylated-19-nor-vitamin D compounds to treat psoriasis |
abstract | A novel use for 1 alpha -hydroxylated-19-nor-vitamin D compounds to treat psoriasis inasmuch as these compounds when administered to humans are converted to a metabolite, such as a 1 alpha ,25-dihydroxylated compound, which metabolite in vitro will cause differentiation in a human cell line. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9295928-B2 |
priorityDate | 1990-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.